Company news

InspireMD Inc. news in 2021

InspireMD Inc.'s news releases, calls and decks from 2021, newest first.

View company

InspireMD Reports Third Quarter 2021 Financial Results and Provides Corporate Update

November 8, 2021

InspireMD Announces Publication of 12-Month Results of CGuard™ EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions

November 2, 2021

InspireMD to Report Third Quarter 2021 Financial Results on November 9, 2021 and Provide Corporate Business Update

October 25, 2021

InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health

October 12, 2021

InspireMD Announces Strong Second Quarter 2021 Financial Results

August 9, 2021

InspireMD to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021, and Provide Corporate Update

August 3, 2021

InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

July 22, 2021

InspireMD Announces Warrants Exchange Listing Transfer to Nasdaq

May 26, 2021

InspireMD Commences Trading on Nasdaq-CM

May 20, 2021

InspireMD Announces Appointment of Katie Arnold to Board of Directors

May 11, 2021

InspireMD Announces First Quarter 2021 Financial Results

May 10, 2021

InspireMD Announces Stock Exchange Listing Transfer to Nasdaq

May 9, 2021

InspireMD to Report First Quarter 2021 Financial Results on Tuesday, May 11, 2021 and Provide Corporate Update

May 3, 2021

InspireMD Appoints Acclaimed Interventional Cardiologist Kenneth Rosenfield, MD as Chair of its Newly Formed Scientific Advisory Board

April 28, 2021

InspireMD Provides Corporate Update for Shareholders

April 18, 2021

InspireMD Announces 1-for-15 Reverse Stock Split

April 13, 2021

InspireMD Announces Fourth Quarter and Year-End 2020 Financial Results

March 8, 2021

InspireMD to Report Fourth Quarter and Year-End 2020 Financial Results on Tuesday, March 9, 2021 and Provide Corporate Update

March 1, 2021

InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States

February 23, 2021

InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States

February 8, 2021

InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

February 7, 2021

InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering

February 3, 2021

Calls in 2021

Decks in 2021